← Back to Search

Single vision contact lens for Near-sightedness

N/A
Waitlist Available
Led By David A Berntsen, OD, PhD
Research Sponsored by David A Berntsen, OD PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of study visit, an average of 3 hours
Awards & highlights

Study Summary

This study will evaluate changes in visual performance at different pupil sizes between a single vision soft contact lens and multifocal soft contact lens, and compare refractive error measured between these two lenses with an autorefractor and an aberrometer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of study visit, an average of 3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of study visit, an average of 3 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual performance
Secondary outcome measures
Refractive error

Trial Design

2Treatment groups
Experimental Treatment
Group I: Single vision contact lensExperimental Treatment1 Intervention
Subjects will wear a single vision soft contact lens during the study visit
Group II: Multifocal contact lensExperimental Treatment1 Intervention
Subjects will wear a multifocal soft contact lens during the study visit
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Single vision contact lens
2022
N/A
~40
Multifocal contact lens
2022
N/A
~40

Find a Location

Who is running the clinical trial?

David A Berntsen, OD PhDLead Sponsor
1 Previous Clinical Trials
16 Total Patients Enrolled
David A Berntsen, OD, PhDPrincipal InvestigatorUniversity of Houston College of Optometry
2 Previous Clinical Trials
101 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Apr 2025